Pfizer, Inc. (NYSE: PFE ) has been a difficult stock to own in the past 20 months. When I initially turned bullish on Pfizer in January 2024, I was expecting Mr. Market to re-rate the company after identifying the massive potential ofDilantha De Silva is an experienced equity analyst and investment researcher with over 10 years in the investment industry. He writes insightful articles for Seeking Alpha, GuruFocus, TipRanks, and ValueWalk, with a significant following on Seeking Alpha. Dilantha’s expertise s ...